The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae
Antimicrobial Agents and Chemotherapy · 16.02.2023
DOI: 10.1128/aac.01279-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 16.02.2023. Verfasst von Ping Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Ceftazidime, Klebsiella Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
In this study, we aimed to clarify the evolutionary trajectory of a Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) population during β-lactam antibiotic therapy. Five KPC-Kp isolates were collected from a single patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
- Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Clinical Laboratory, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China.
- Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
ORCID-Profile: Xueqing Wu, Xiaoting Hua, Alan McNally, Yunsong Yu, Xiaoxing Du
Förderung
- Medical Research Council
- NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, P., Hu, H., Shi, Q., Sun, L., Wu, X., Hua, X., McNally, A., Jiang, Y., Yu, Y., & Du, X. (2023). The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01279-22
Vancouver
Zhang P, Hu H, Shi Q, Sun L, Wu X, Hua X, et al. The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01279-22
BibTeX
@article{Zhang2023,
author = {Zhang, Ping and Hu, Huangdu and Shi, Qiucheng and Sun, Long and Wu, Xueqing and Hua, Xiaoting and McNally, Alan and Jiang, Yan and Yu, Yunsong and Du, Xiaoxing},
title = {The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01279-22}
}
EUVIMED